Last reviewed · How we verify
inhalation of afatinib dimaleate
inhalation of afatinib dimaleate is a Biologic drug developed by Petrov, Andrey. It is currently in Phase 1 development. Also known as: Afatinib Dimaleate, BIBW2992 Dimaleate.
At a glance
| Generic name | inhalation of afatinib dimaleate |
|---|---|
| Also known as | Afatinib Dimaleate, BIBW2992 Dimaleate |
| Sponsor | Petrov, Andrey |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- inhalation of afatinib dimaleate CI brief — competitive landscape report
- inhalation of afatinib dimaleate updates RSS · CI watch RSS
- Petrov, Andrey portfolio CI
Frequently asked questions about inhalation of afatinib dimaleate
What is inhalation of afatinib dimaleate?
inhalation of afatinib dimaleate is a Biologic drug developed by Petrov, Andrey.
Who makes inhalation of afatinib dimaleate?
inhalation of afatinib dimaleate is developed by Petrov, Andrey (see full Petrov, Andrey pipeline at /company/petrov-andrey).
Is inhalation of afatinib dimaleate also known as anything else?
inhalation of afatinib dimaleate is also known as Afatinib Dimaleate, BIBW2992 Dimaleate.
What development phase is inhalation of afatinib dimaleate in?
inhalation of afatinib dimaleate is in Phase 1.
Related
- Manufacturer: Petrov, Andrey — full pipeline
- Also known as: Afatinib Dimaleate, BIBW2992 Dimaleate
- Compare: inhalation of afatinib dimaleate vs similar drugs
- Pricing: inhalation of afatinib dimaleate cost, discount & access